Orthofix Pleads Guilty, Pays $42M In Fines, Penalties For Device Sales Tactics

Orthofix Pleads Guilty, Pays $42M In Fines, Penalties For Device Sales Tactics

BOSTON - Orthofix Inc. on June 7 pleaded guilty to a federal felony count of obstructing a federal audit and agreed to pay nearly $42 million in criminal fines and civil penalties for illegal promotion of its bone-growth stimulators (United States of America v. Orthofix, Inc., No. 1:12-cr-10169, United States of America, ex rel. Jeffrey Bierman v. Orthofix International, N.V., et al., No. 1:05-cv-10557, D. Mass.). Review a complimentary copy of the complete Mealey's Emerging Drugs & Devices Bulletin.

Find full version on lexis Advance®
Access this news story on lexis.com®